Alexis Finkelberg Bortniker has joined Cooley’s San Diego office as a partner in the firm’s global life sciences and healthcare regulatory practice group. Bortniker arrives from Foley & Lardner, where she co-chaired its healthcare transaction group and its healthcare and life sciences sector’s payer/provider convergence area of focus. Her practice focuses on health regulatory counseling and transactional matters advising technology-based innovators and disruptors shaping the new healthcare landscape.
“Alexis’ extensive experience as a strategic adviser to healthcare companies at every stage in their life cycle will undoubtedly serve as a valuable resource to our innovative clients who are changing the healthcare landscape,” said Sonya Erickson, Cooley partner and chair of the firm’s business department. “As a sharp healthcare transactional lawyer, she further elevates Cooley’s standing as a market-leading life sciences firm, enhancing our regulatory capabilities and enabling us to meet the needs of our expanding digital health client base.”
“We are beyond thrilled to welcome Alexis to our growing regulatory team,” said Sonia Nath, chair of the firm’s global life sciences and healthcare regulatory practice group. “Her familiarity with the quickly evolving health sector, leadership acumen and experience representing the full gamut of clients – from startups to investors and established commercial companies – will help us meet the increasing needs of our innovative life sciences and digital health clients.”
Bortniker brings a broad range of experience advising healthcare providers, digital health and healthtech companies, payers, private equity firms and technology companies on joint ventures, mergers & acquisitions, payment structures, pricing and reimbursement work, and complex business transactions. She also has a deep understanding of telehealth laws and brings a strong skillset in the mergers & acquisitions of medical practices, as well as the formation of third-party administrators and other highly regulated entities in the healthcare sector.
“Cooley’s reputation as a trusted adviser to some of the world’s most cutting-edge life sciences and healthcare companies is unmatched. I am delighted to be joining this world-class team of corporate and regulatory practitioners,” said Bortniker. “I look forward to leveraging Cooley’s leading transactional capabilities in advising the world’s foremost digital health leaders – and joining in the firm’s unique and collaborative culture.”
Bortniker is the latest addition to the firm’s expanding global life sciences and healthcare capabilities. Cooley’s top-tier life sciences and healthcare corporate, regulatory, and litigation lawyers have extensive global and US experience counseling on a vast scope of complex healthcare deals, regulatory issues and investigations. The firm has represented leading global life sciences companies for 40+ years and advises all players in the ecosystem, including payers, providers, companies, health IT and investors. Cooley is consistently recognized as a market leader in the field according to Law360, LMG Life Sciences, Chambers and The Legal 500, among others. Most recently, Cooley was named as Law360’s Life Sciences Practice Group of the Year, and LMG Life Sciences has recognized the firm in consecutive years in the United States and the United Kingdom.
Source: www.cooley.com
